Table 2.
Male (n = 38) | Female (n = 27) | |
No engraftment | 01 | 02 |
Engraftment | 37 | 25 |
Neutrophil engraftment (day) | 13.00 | 16.00 |
(10.00/19.00) | (11.00/19.00) | |
Platelet engraftment (day) | 16.00 | 20.00 |
(12.00/21.00) | (13.00/23.00) | |
OS (<6 months) | 36/38 (94.74%) | 23/27 (85.18%) |
OS (6–12 months) | 31/38 (81.58%) | 21/27 (77.78%) |
OS: overall survival; Neutrophil and platelet engraftment were expressed as median (lower/upper quartile).